No connection

Search Results

BRKRP

BEARISH
$401.9 Live
Bruker Corporation · NASDAQ
$250.0 52W Range $419.83
Overview AI Snowflake Price Valuation Profitability Growth Health

At a glance

Key valuation, profitability, growth, and risk metrics.

Updated Jan 24, 2026
Market cap
N/A
P/E
N/A
ROE
-1.1%
Profit margin
-0.6%
Debt/Equity
0.82
Dividend yield
3.66%

AI Analysis

AI-powered fundamental assessment

Confidence
78%
The Advanced Deterministic Scorecard reveals a weak fundamental posture with a Piotroski F-Score of just 2/9, indicating poor financial health. Despite a strong operating margin and solid gross profitability, the company is burdened by negative earnings, negative ROE, and lack of reliable valuation benchmarks. Revenue is flat, cash flow metrics are missing, and the technical trend is deeply bearish. While the dividend yield is high at 3.66%, the lack of earnings coverage and weak profitability cast serious doubt on its sustainability.

Key Strengths

High gross margin of 48.83% indicates strong pricing power or cost control in core operations
Operating margin of 12.96% remains healthy relative to sector averages
Current ratio of 1.85 suggests adequate short-term liquidity
Debt/Equity of 0.82 is below sector average of 2.46, indicating conservative leverage
High dividend yield of 3.66% may attract income-focused investors

Key Risks

Piotroski F-Score of 2/9 signals severe financial distress and weak earnings quality
Negative profit margin (-0.61%) and negative ROE (-1.09%) indicate unprofitability
Revenue growth is negative YoY (-0.50%), showing contraction in top line
Technical trend score of 10/100 reflects strong bearish momentum
Missing Altman Z-Score and intrinsic value prevent reliable distress and valuation assessment

Performance Snowflake

Multi-dimensional analysis across 5 key categories

Overall
33
Weak
Value
25
Future
30
Past
55
Health
20
Dividend
35
AI Verdict
High risk, low quality, and deteriorating fundamentals with unsustainable yield
Key drivers: Low Piotroski F-Score, Negative earnings and ROE, Bearish technical trend, Lack of analyst coverage, Unsustainable dividend relative to earnings
Confidence
75%
Value
25/100

Ref P/E, PEG, Graham Number

Positives
No standout positives identified.
Watchpoints
  • No P/E, Forward P/E, or PEG available
  • Price/Book of 25.02 is extremely high given negative earnings
  • No Graham Number or intrinsic value estimate
Future
30/100

Ref Growth rates

Positives
  • Sector has high average revenue growth (73.39%)
Watchpoints
  • Company's YoY revenue growth is -0.50%
  • No Q/Q growth data available
  • No earnings growth data suggests instability
Past
55/100

Ref Historical trends

Positives
  • 5-year price return of +62.2% outperforms most peers
  • Recent 1-month and 1-week gains suggest short-term momentum
Watchpoints
  • Lack of historical averages (50-day, 200-day) limits trend confirmation
  • Peer group has largely collapsed, making relative performance misleading
Health
20/100

Ref Altman Z-Score, Piotroski F-Score

Positives
  • Current ratio of 1.85 supports short-term solvency
  • Debt/Equity below sector average
Watchpoints
  • Piotroski F-Score of 2/9 indicates critical financial weakness
  • Negative ROE and profit margin
  • Quick ratio of 0.84 suggests potential liquidity strain if inventory cannot be liquidated
Dividend
35/100

Ref Yield, Payout

Positives
  • Dividend yield of 3.66% is attractive on surface
Watchpoints
  • No payout ratio available raises sustainability concerns
  • Negative earnings make dividend coverage impossible
  • Dividend strength score of 20/100 indicates high risk

Stock Price & Analyst Targets

Real-time price movements and analyst price targets

Current Price
$401.9

Multi-Horizon Performance vs Peers

Price momentum across 5Y → 1W horizons for BRKRP and closest competitors.

Updated 2026-01-23
BRK
Bruker Corporation
Primary
5Y
+62.2%
3Y
+62.2%
1Y
+62.2%
6M
+62.2%
1M
+8.1%
1W
+6.4%

Positive values indicate cumulative gains over the specified period. Comparables pulled from the same sector to highlight whether momentum is stock-specific or industry-wide.

Historical Performance Trends

Long-term financial metrics and growth patterns

Revenue & Net Income

Profit & Operating Margins

Return on Equity (ROE)

Quarterly Revenue Growth

Historical data shows last 12 quarters (3 years)

Valuation Metrics

Key valuation ratios and pricing indicators

P/E Ratio
N/A
Forward P/E
N/A
PEG Ratio
N/A
P/B Ratio
25.02
P/S Ratio
N/A
EV/Revenue
18.29
EV/EBITDA
107.49
Market Cap
N/A

Profitability

Profit margins and return metrics

Profit Margin -0.61%
Operating Margin 12.96%
Gross Margin 48.83%
ROE -1.09%
ROA 3.69%

Growth

Revenue and earnings growth rates

Revenue Growth -0.5%
Earnings Growth N/A
Q/Q Revenue Growth N/A
Q/Q Earnings Growth N/A

Financial Health

Balance sheet strength and liquidity metrics

Debt/Equity
0.82
Moderate
Current Ratio
1.85
Good
Quick Ratio
0.84
Poor
Cash/Share
$1.94

Healthcare Sector Comparison

Comparing BRKRP against 560 companies in the Healthcare sector (34 bullish, 167 neutral, 359 bearish)
Return on Equity (ROE)
-1.09%
This Stock
vs
-88.14%
Sector Avg
-98.8% (Below Avg)
Profit Margin
-0.61%
This Stock
vs
-16.28%
Sector Avg
-96.3% (Weaker)
Debt to Equity
0.82
This Stock
vs
2.66
Sector Avg
-69.1% (Less Debt)
Revenue Growth
-0.5%
This Stock
vs
124.04%
Sector Avg
-100.4% (Slower)
Current Ratio
1.85
This Stock
vs
4.47
Sector Avg
-58.6% (Weaker)

Past News Coverage

Recent headlines mentioning BRKRP from our newsroom.

Newest → oldest
Back to All Stocks
TradingGPT V2 Copilot
Fundamentals • Valuation • Risk
Hi! I'm your fundamentals copilot.

Ask me to:
• Summarize the business quality
• Review valuation and multiples
• Highlight risks and red flags
• Explain growth and margin trends
Features Terminal AI Assistant Analysis Market News Pricing
Start Trading with AI Already have an account? Sign In
Home
Terminal
AI Chat
Markets
Profile